Department of Endocrinology and Diabetology;
Saitama Medical University;
Saitama;
Japan;
Department of Health Sciences;
Saitama Prefectural University;
Saitama;
Japan;
Research and Development Department;
Advanced Materials Development Sector;
Tokyo Metropolitan Industrial Technology Research Institute;
Tokyo;
Japan;
Division of Morphological Science;
Biomedical Research Center;
Saitama Medical University;
Saitama;
Japan;
Department of Biochemistry;
Saitama Medical University;
Saitama;
Japan;
PCSK9; Inhibitor; Evolocumab; LDL; Heterogeneicity; Small; Size; LDL; 3; PAGE; 2; -; 16; GGE;